 
    The liquid-phase technique provides an alternative to the extensively employed solid-phase oligonucleotide synthesis method. In this strategy, a soluble polymeric carrier integrated into the reaction medium acts as the scaffold for elongating the chain. Afterward, the polymer is separated from unused reagents and soluble by-products using filtration or crystallization techniques. This approach eliminates any inconsistency resulting from support insolubility, thus enhancing the potential for process upscaling. This is particularly pertinent now as synthetic oligonucleotides are transitioning from research settings to practical biomedical applications. Consequently, the scientific community is actively exploring the development and evaluation of a more user-friendly liquid-phase chemical synthesis method for oligonucleotides. An innovative strategy known as high-performance liquid phase (HELP), utilizing soluble polyethylene glycol (PEG) as a polymeric support and employing phosphotriester chemistry for the coupling reaction, has demonstrated promising outcomes.
Our liquid-phase synthesis platform is built upon a modified phosphoramidite chemistry, the most widely used technique for DNA and RNA synthesis. Unlike solid-phase synthesis, which uses an insoluble support, our liquid-phase oligonucleotide synthesis method utilizes a soluble polymeric support that remains dissolved in the reaction solvent. This homogeneous reaction environment provides several key advantages, including better reagent accessibility and more predictable, linear reaction kinetics. This approach allows for a reduction in the large excesses of expensive amidite monomers typically required in solid-phase methods to drive reactions to completion. Our innovative "one-pot" liquid-phase oligonucleotide technique for DNA synthesis allows for sequential coupling, oxidation, and deprotection in a single reaction vessel, followed by a single precipitation step, drastically streamlining the process and reducing overall solvent consumption.
CD BioGlyco commits to providing global clients with industry-leading Custom Carbohydrate Synthesis services, such as Custom Sugar-nucleotides Synthesis services. The HELP-based Synthesis of Oligonucleotides we provide mainly includes 3 key steps: functionalization of PEG, oligonucleotide assembly, deprotection & purification.
 Fig.1 Process of HELP for oligonucleotide synthesis. (CD BioGlyco)
Fig.1 Process of HELP for oligonucleotide synthesis. (CD BioGlyco)
DOI.: 10.1021/acs.oprd.5c00117
Journal: Organic Process Research & Development
Published: 2025
IF: 3.5
Results: Employing solvent-defying ceramic membranology, this scalable one-pot approach revolutionizes liquid-phase oligonucleotide fabrication. Authors covalently tethered elongating phosphorothioate 2'-O-methyl oligonucleotides to branched-polyethylene-glycol matrices, artfully integrating iterative phosphoramidite coupling, sulfurization, and acid-mediated detritylation. Membrane-filtration purification occurs concomitantly, streamlining processes traditionally necessitating laborious intermediate isolations, a synthesis strategy embodying stoichiometric precision and macromolecular engineering ingenuity. Using ultrafiltration and nanofiltration ceramic membranes, they achieved high stepwise filtration yields and crude purity with only 1.5 equivalents of phosphoramidites. The membranes selectively retained PEG-oligonucleotide conjugates while removing low-MW impurities. This approach reduced unit operations, solvent consumption, and process mass intensity compared to solid-phase synthesis, demonstrating feasibility for gram-scale therapeutic oligonucleotide production with efficient intermediate purification.
Liquid-phase chemical synthesis for oligonucleotides, leveraging soluble polymer supports (e.g., PEG) and homogeneous reaction conditions, enables scalable, cost-effective production of DNA/RNA sequences with reduced reagent consumption and streamlined purification via precipitation or membrane filtration. Forwarding glycotherapeutic vectors and nucleic-acid-conjugate integrations, this platform necessitates co-delivered-associated enzymatic services: concerted enzymatic catalysis fabricates nucleotide sugar donors satisfying exacting purity specifications.
At CD BioGlyco, we have established the high-quality Glyco™ Synthesis Platform that is dedicated to glycobiology research. Our commitment to excellence is evident in every aspect of the Chemical-based Oligonucleotide Synthesis Service. Our team is dedicated to maintaining the highest standards and ensuring client satisfaction, particularly in the realm of liquid-phase chemical synthesis methods for oligonucleotides. If you are interested in our services, please do not hesitate to contact us for more details.
Reference
